Sunitinib malate for the treatment of pancreatic neuroendocrine tumors E Raymond, L Dahan, JL Raoul, YJ Bang, I Borbath, C Lombard-Bohas, ... New England Journal of Medicine 364 (6), 501-513, 2011 | 2983 | 2011 |
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors J Strosberg, G El-Haddad, E Wolin, A Hendifar, J Yao, B Chasen, E Mittra, ... New England Journal of Medicine 376 (2), 125-135, 2017 | 2919 | 2017 |
Gastroenteropancreatic neuroendocrine tumours IM Modlin, K Oberg, DC Chung, RT Jensen, WW De Herder, RV Thakker, ... The lancet oncology 9 (1), 61-72, 2008 | 2063 | 2008 |
Lanreotide in metastatic enteropancreatic neuroendocrine tumors ME Caplin, M Pavel, JB Ćwikła, AT Phan, M Raderer, E Sedláčková, ... New England Journal of Medicine 371 (3), 224-233, 2014 | 2016 | 2014 |
Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial JC Yao, C Lombard-Bohas, E Baudin, LK Kvols, P Rougier, ... Journal of clinical oncology 28 (1), 69-76, 2010 | 795 | 2010 |
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system K Öberg, L Kvols, M Caplin, G Delle Fave, W de Herder, G Rindi, ... Annals of Oncology 15 (6), 966-973, 2004 | 747 | 2004 |
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary … ME Caplin, E Baudin, P Ferolla, P Filosso, M Garcia-Yuste, E Lim, ... Annals of Oncology 26 (8), 1604-1620, 2015 | 671 | 2015 |
Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies F Huguet, T André, P Hammel, P Artru, J Balosso, F Selle, ... Journal of Clinical Oncology 25 (3), 326-331, 2007 | 643 | 2007 |
Risk of pancreatic adenocarcinoma in chronic pancreatitis D Malka, P Hammel, F Maire, P Rufat, I Madeira, F Pessione, P Levy, ... Gut 51 (6), 849-852, 2002 | 638 | 2002 |
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours U Plöckinger, G Rindi, R Arnold, B Eriksson, EP Krenning, WW De Herder, ... Neuroendocrinology 80 (6), 394-424, 2004 | 631 | 2004 |
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct P Hammel, A Couvelard, D O'Toole, A Ratouis, A Sauvanet, JF Fléjou, ... New England Journal of Medicine 344 (6), 418-423, 2001 | 583 | 2001 |
TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study G Rindi, M Falconi, C Klersy, L Albarello, L Boninsegna, MW Buchler, ... Journal of the National Cancer Institute 104 (10), 764-777, 2012 | 544 | 2012 |
ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms G Delle Fave, D O''Toole, A Sundin, B Taal, P Ferolla, JK Ramage, ... Neuroendocrinology 103 (2), 119-124, 2016 | 523 | 2016 |
Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct B Terris, P Ponsot, F Paye, P Hammel, A Sauvanet, G Molas, P Bernades, ... The American journal of surgical pathology 24 (10), 1372-1377, 2000 | 486 | 2000 |
Risk factors for diabetes mellitus in chronic pancreatitis D Malka, P Hammel, A Sauvanet, P Rufat, D O'Toole, P Bardet, J Belghiti, ... Gastroenterology 119 (5), 1324-1332, 2000 | 472 | 2000 |
Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses M Voss, P Hammel, G Molas, L Palazzo, A Dancour, D O'toole, B Terris, ... Gut 46 (2), 244-249, 2000 | 472 | 2000 |
Pancreatic involvement in von Hippel–Lindau disease PR Hammel, V Vilgrain, B Terris, A Penfornis, A Sauvanet, JM Correas, ... Gastroenterology 119 (4), 1087-1095, 2000 | 467 | 2000 |
Assessment of complications of EUS-guided fine-needle aspiration D O'Toole, L Palazzo, R Arotçarena, A Dancour, A Aubert, P Hammel, ... Gastrointestinal endoscopy 53 (4), 470-474, 2001 | 456 | 2001 |
Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy S Gaujoux, A Cortes, A Couvelard, S Noullet, L Clavel, V Rebours, P Lévy, ... Surgery 148 (1), 15-23, 2010 | 416 | 2010 |
ENETS consensus guidelines for the management of patients with gastroduodenal neoplasms G Delle Fave, DJ Kwekkeboom, E Van Cutsem, G Rindi, B Kos-Kudla, ... Neuroendocrinology 95 (2), 74-87, 2012 | 411 | 2012 |